Literature DB >> 21900378

Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma.

Jaroslaw Jendrzejewski1, Jerneja Tomsic, Gerard Lozanski, Jadwiga Labanowska, Huiling He, Sandya Liyanarachchi, Rebecca Nagy, Matthew D Ringel, Richard T Kloos, Nyla A Heerema, Albert de la Chapelle.   

Abstract

CONTEXT: The family risk ratio for papillary thyroid carcinoma (PTC) is among the highest of all cancers. Collectively, familial cases (fPTC) and sporadic cases (sPTC) are not known to show molecular differences. However, one study reported that telomeres were markedly shorter and the telomerase reverse transcriptase (TERT) gene was amplified and up-regulated in germline DNA from patients with fPTC compared with sPTC.
OBJECTIVE: The aim of this study was to evaluate telomere length and TERT gene amplification and expression in blood samples of fPTC and sPTC patients in a genetically distinct population from the previous study.
DESIGN: In 42 fPTC and 65 sPTC patients, quantitative real-time PCR was employed to measure the relative telomere length (RTL) and TERT gene copy number and RNA level. To validate the results using alternative methods, we further studied a subset of the original cohort consisting of randomly chosen fPTC (n = 10) and sPTC (n = 14) patients and controls (n = 21) by assessing both telomere length by flow fluorescent in situ hybridization and TERT gene expression by quantitative real-time PCR.
RESULTS: RTL and TERT gene copy number did not differ between fPTC and sPTC (P = 0.957 and P = 0.998, respectively). The mean RTL and TERT gene expression were not significantly different among the groups of the validation series (P = 0.169 and P = 0.718, respectively).
CONCLUSION: Our data show no difference between familial and sporadic PTC with respect to telomere length, TERT copy number, or expression in our cohort. Further investigations in additional cohorts of patients are desirable.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900378      PMCID: PMC3205886          DOI: 10.1210/jc.2011-1643

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.

Authors:  C Dong; K Hemminki
Journal:  Int J Cancer       Date:  2001-04-01       Impact factor: 7.396

3.  Telomere length and possible link to X chromosome.

Authors:  Tim S Nawrot; Jan A Staessen; Jeffrey P Gardner; Abraham Aviv
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

4.  Telomere length and heredity: Indications of paternal inheritance.

Authors:  Katarina Nordfjäll; Asa Larefalk; Petter Lindgren; Dan Holmberg; Göran Roos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

5.  Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.

Authors:  Junji Uchino; Koichi Takayama; Akiko Harada; Yosuke Kawakami; Hiroyuki Inoue; David T Curiel; Yoichi Nakanishi
Journal:  Cancer Gene Ther       Date:  2005-09       Impact factor: 5.987

6.  Association between telomere length in blood and mortality in people aged 60 years or older.

Authors:  Richard M Cawthon; Ken R Smith; Elizabeth O'Brien; Anna Sivatchenko; Richard A Kerber
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

7.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.

Authors:  Krystian Jazdzewski; Sandya Liyanarachchi; Michal Swierniak; Janusz Pachucki; Matthew D Ringel; Barbara Jarzab; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

8.  Telomere length in the newborn.

Authors:  Koji Okuda; Arlene Bardeguez; Jeffrey P Gardner; Paulette Rodriguez; Vijaya Ganesh; Masayuki Kimura; Joan Skurnick; Girgis Awad; Abraham Aviv
Journal:  Pediatr Res       Date:  2002-09       Impact factor: 3.756

9.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

10.  Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer.

Authors:  Silvia Cantara; Serena Capuano; Caterina Formichi; Milena Pisu; Marco Capezzone; Furio Pacini
Journal:  Thyroid Res       Date:  2010-08-11
View more
  4 in total

Review 1.  Controversies in familial thyroid cancer 2014.

Authors:  Orlo H Clark
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

Review 2.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

3.  Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.

Authors:  Mei He; Brent Bian; Krisana Gesuwan; Neelam Gulati; Lisa Zhang; Naris Nilubol; Electron Kebebew
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

Review 4.  Familial non-medullary thyroid cancer: a critical review.

Authors:  M Capezzone; E Robenshtok; S Cantara; M G Castagna
Journal:  J Endocrinol Invest       Date:  2020-10-06       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.